These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2163796)

  • 1. GM2-gangliosidosis. Clinical and biochemical aspects of four cases.
    Praamstra P; Wevers RA; Gabreëls FJ; Rotteveel JJ; Renier WO; Sengers RC; Lamers KJ
    Clin Neurol Neurosurg; 1990; 92(2):143-8. PubMed ID: 2163796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
    Christopher R; Rangaswamy GR; Shetty KT
    Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme studies in GM2 gangliosidiosis, and their application in prenatal diagnosis.
    Kaur M; Verma IC
    Indian J Pediatr; 1995; 62(4):485-9. PubMed ID: 10829910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM2 gangliosidosis with a motor neuron disease phenotype: clinical heterogeneity of hexosaminidase deficiency disease.
    Federico A
    Adv Exp Med Biol; 1987; 209():19-23. PubMed ID: 2953177
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromatofocusing coupled with automated assay for beta-hexosaminidase isoenzymes in GM2 gangliosidosis.
    Orlacchio A; Maffei C; Emiliani C; Coppa GV; Felici L
    Experientia; 1985 Apr; 41(4):525-7. PubMed ID: 3157597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
    Inui K; Wenger DA
    Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta.
    Akeboshi H; Chiba Y; Kasahara Y; Takashiba M; Takaoka Y; Ohsawa M; Tajima Y; Kawashima I; Tsuji D; Itoh K; Sakuraba H; Jigami Y
    Appl Environ Microbiol; 2007 Aug; 73(15):4805-12. PubMed ID: 17557860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma G
    Blondel A; Kraoua I; Marcelino C; Khrouf W; Schlemmer D; Ganne B; Caillaud C; Fernández-Eulate G; Turki IBY; Dauriat B; Bonnefont-Rousselot D; Nadjar Y; Lamari F
    Mol Genet Metab; 2023 Feb; 138(2):106983. PubMed ID: 36709536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of keratan sulfate by beta-N-acetylhexosaminidases in GM2-gangliosidosis.
    Yutaka T; Okada S; Kato T; Yabuuhi H
    Clin Genet; 1982 Mar; 21(3):196-202. PubMed ID: 6212169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [GM2 gangliosidosis].
    Tsuji S
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):177-9. PubMed ID: 10434623
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent advances in molecular genetics of GM2 gangliosidosis].
    Wakamatsu N
    Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tay-Sachs and Sandhoff diseases: enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards.
    Chamoles NA; Blanco M; Gaggioli D; Casentini C
    Clin Chim Acta; 2002 Apr; 318(1-2):133-7. PubMed ID: 11880123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired degradation of chondroitin sulfate in GM2-gangliosidosis.
    Yutaka T; Kato T; Okada S; Yabuuci H
    Clin Genet; 1982 Oct; 22(4):165-71. PubMed ID: 6217929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
    Suzuki K; Vanier MT
    Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
    Harzer K
    Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adult form of GM2-gangliosidosis: a man and 2 sisters with hexosaminidase-A and -B deficiency (Sandhoff disease) and literature review].
    Schnorf H; Bosshard NU; Gitzelmann R; Spycher MA; Isler P; Waespe W
    Schweiz Med Wochenschr; 1996 May; 126(18):757-64. PubMed ID: 8693300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity.
    Specola N; Vanier MT; Goutières F; Mikol J; Aicardi J
    Neurology; 1990 Jan; 40(1):145-50. PubMed ID: 2136940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sandhoff disease: a prevalent form of infantile GM2 gangliosidosis in Lebanon.
    Der Kaloustian VM; Khoury MJ; Hallal R; Idriss ZH; Deeb ME; Wakid NW; Haddad FS
    Am J Hum Genet; 1981 Jan; 33(1):85-9. PubMed ID: 7468596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive dystonia symptomatic of juvenile GM2 gangliosidosis.
    Nardocci N; Bertagnolio B; Rumi V; Angelini L
    Mov Disord; 1992; 7(1):64-7. PubMed ID: 1532632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta-N-acetyl-hexosaminidase--the enzyme of Tay-Sachs and Sandhoff diseases].
    Zwierz K; Juszkiewicz J; Arciuch L; Gindzieński A
    Postepy Biochem; 1992; 38(3):127-32. PubMed ID: 1461844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.